Business

Green ammonia plant

World’s first green ammonia plant is now open for business in Denmark

| By | -, Change Milestones

The new plant – located in Ramme, Denmark – is said to be capable of producing 5,000 tons of green ammonia per year, entirely from solar and wind energy. Topsoe reports that this effort will prevent 8,200 tons of carbon dioxide emissions annually. Gray ammonia production – which uses fossil fuels – is currently the norm around the globe, and accounts for about 1.2% of all carbon dioxide emissions.

World’s first green ammonia plant is now open for business in Denmark Read more

Aerial view of large solar farm

World’s biggest battery storage project gets underway in Chile

| By | -, Change Milestones

Financial close has been reached for the first two phases of the world’s largest battery storage project, the Oasis de Atacama in Chile, with 1.24GWh now financed and an eventual 4.1GWh once all five phases are completed. Grenergy expects the completed project will generate electricity equivalent for the needs of 145,000 homes and reduce CO2 emissions by over 146,000 tons.

World’s biggest battery storage project gets underway in Chile Read more

Model lungs

World-first lung cancer vaccine trials launched across seven countries

| By | -, Change Milestones

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8 million deaths every year. Now experts are testing a new jab that instructs the body to hunt down and kill cancer cells – then prevents them from ever coming back. Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer, the most common form of the disease. The phase 1 clinical trial, the first human study of BNT116, has launched across 34 research sites in seven countries: the U.K., U.S., Germany, Hungary, Poland, Spain, and Turkey.

World-first lung cancer vaccine trials launched across seven countries Read more

Solar farm

New Zealand’s biggest solar farm secures finance to go ahead at Christchurch Airport

| By | -, Change Milestones

Leading global renewable energy developer Lightsource BP has secured $NZ267 million in financing for its 168MW Kōwhai Park solar project planned to be built at the Christchurch Airport, which will be – for a time – the largest in the country. The solar farm is expected to begin construction later this year and begin operations some time in 2026. Once operational, the Kōwhai Park solar farm will generate over 275GWh per year, equivalent to the annual demand of approximately 36,000 homes.

New Zealand’s biggest solar farm secures finance to go ahead at Christchurch Airport Read more

Mt. Everest

Chinese drones to transport trash from Nepal’s Mount Everest

| By | -, Change Milestones

Nepal is set to deploy Chinese-made drones to transport garbage from the slopes of Everest, marking the first time unmanned aerial vehicles (UAVs) will be used commercially in the country’s high-altitude zones. This initiative announced by China’s leading drone manufacturer, Da Jiang Innovations aims to reduce the risks faced by Sherpas and improve waste management on the world’s tallest peak.

Chinese drones to transport trash from Nepal’s Mount Everest Read more

Mickey and Minnie Mouse at Disneyland

Disneyland unions agree to ‘historic’ 31% pay raise

| By | -, Change Milestones

Master Services Council, which represents 14,000 Disneyland, Disney California Adventure, and Downtown Disney employees from four unions, announced its members had voted to accept a new contract that provides a 31% pay raise over the next three years.
The “biggest wage increases ever” for Disneyland resort employees will raise hourly pay more than $6 over three years from the current $19.90 to $24 in 2024 and $26 in 2026, according to the unions.

Disneyland unions agree to ‘historic’ 31% pay raise Read more

Vials of blood

U.S. Food and Drug Administration approves blood test to screen for colon cancer

| By | -, Change Milestones

The test, known as Shield, isn’t meant to replace colonoscopies, but is generating enthusiasm among doctors who say it has the potential to boost the dismal rate of screenings for the second-highest cause of cancer death in the United States. Shield has previously been available to doctors as a screening tool, at an out-of-pocket cost of $895. With the FDA approval, Medicare and private insurance companies are much more likely to cover the cost of the blood test, making it more widely accessible for patients.

U.S. Food and Drug Administration approves blood test to screen for colon cancer Read more

Ocean Energy grid-scale wave energy generator Hawaii

Revolutionary grid-scale wave energy generator deployed in Hawaii

| By | -, Change Milestones

Ocean Energy has deployed its 826-tonne wave energy converter buoy OE-35 at the US Navy’s Wave Energy Test Site off the coast of the island of Oahu ahead of it being hooked up to Hawaii’s electricity grid. With a potential output of 1.25 MW, OE-35 harnesses energy from the waves using a remarkable double-flow air system.

Revolutionary grid-scale wave energy generator deployed in Hawaii Read more

Fervo Energy geothermal plant

World’s biggest geothermal power purchase agreement completed in western U.S.

| By | -, Change Milestones

It’s only been one year since Fervo Energy unveiled a novel concept in geothermal energy harvesting at its Project Red pilot plant in Nevada. Now the company has signed a 15-year agreement with Southern California Edison to provide 320 MW of power to the utility, which will power about 350,000 homes. The power will be provided by Fervo’s Cape Station project that is currently being built in southwest Utah, with the first 70 MW coming online in 2026 and the balance clicking on in 2028.

World’s biggest geothermal power purchase agreement completed in western U.S. Read more

HIV virus

New twice-yearly shot to prevent HIV achieves 100% success rate in late-stage trial

| By | -, Change Milestones

In this double-blind, randomized study of 5,300 cisgender women in South Africa and Uganda, 2,134 got the injection and the others took one of two types of daily PrEP pills. The trial from California-based company Gilead Sciences began on August 2021 and, so far, not a single woman who received the injections has contracted HIV. The participants who received either of the oral PrEP options, Truvada and Descovy, had infection rates of about 2% — consistent with the infection rates of oral PrEP in other clinical trials.

New twice-yearly shot to prevent HIV achieves 100% success rate in late-stage trial Read more

Start typing and press enter to search